Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious?

Int J Dermatol. 2014 Mar;53(3):e211-2. doi: 10.1111/ijd.12127. Epub 2013 Jun 20.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Antitubercular Agents / administration & dosage*
  • Antitubercular Agents / adverse effects
  • Female
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Isoniazid / administration & dosage*
  • Isoniazid / adverse effects
  • Latent Tuberculosis / drug therapy*
  • Male
  • Middle Aged
  • Prospective Studies
  • Psoriasis / drug therapy*

Substances

  • Antibodies, Monoclonal, Humanized
  • Antitubercular Agents
  • Immunosuppressive Agents
  • Isoniazid